Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Spread of the SARS-CoV-2 UK-variant in the South East of France: impact on COVID-19 patients’ age, comorbidity profiles and clinical presentation

Johan Courjon, Julie Contenti, Elisa Demonchy, Jacques Levraut, Pascal Barbry, Géraldine Rios, Jean Dellamonica, David Chirio, Caroline Bonnefoy, Valérie Giordanengo, Michel Carles
doi: https://doi.org/10.1101/2021.04.12.21253817
Johan Courjon
1Infectious Diseases Department, Université Côte d’Azur, CHU Nice, Nice, France
2Université Côte d’Azur, Inserm, U1065, C3M, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: courjon.j@chu-nice.fr
Julie Contenti
2Université Côte d’Azur, Inserm, U1065, C3M, Nice, France
3Emergency Department, Université Côte d’Azur, CHU Nice, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisa Demonchy
1Infectious Diseases Department, Université Côte d’Azur, CHU Nice, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacques Levraut
3Emergency Department, Université Côte d’Azur, CHU Nice, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascal Barbry
4Institut de Pharmacologie Moleculaire et Cellulaire, UMR7275 CNRS/UNS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Géraldine Rios
4Institut de Pharmacologie Moleculaire et Cellulaire, UMR7275 CNRS/UNS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Dellamonica
5Medical Intensive Care Unit Department, Université Côte d’Azur, CHU Nice, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Chirio
1Infectious Diseases Department, Université Côte d’Azur, CHU Nice, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Bonnefoy
6Virology Department, Université Côte d’Azur, CHU Nice, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valérie Giordanengo
2Université Côte d’Azur, Inserm, U1065, C3M, Nice, France
6Virology Department, Université Côte d’Azur, CHU Nice, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Carles
1Infectious Diseases Department, Université Côte d’Azur, CHU Nice, Nice, France
2Université Côte d’Azur, Inserm, U1065, C3M, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives The variant 20I/501Y.V1, associated to a higher risk of transmissibility, emerged in Nice city (South East of France, French Riviera) during January 2021. The pandemic has resumed late December 2020 in this aera. A high incidence rate together with a fast turn-over of the main circulating variants, provided us the opportunity to analyze modifications in clinical profile and outcome traits.

Methods Observational study in the University hospital of Nice from December 2020 to February 2021. We analyzed data of sequencing of SARS-CoV-2 from the sewage collector and PCR screening from all positive samples at the hospital. Then, we described the characteristics of all COVID-19 patients admitted in the emergency department (ED) (n=1247) and those hospitalized in the infectious diseases ward or ICU (n=232). Demographic data, clinical signs and severity were recorded by the NEWS-2, SAPS-2 and SOFA scores were recorded and analyzed.

Results the UK-variant was absent in the area in December, then increasingly spread in January representing 59% of the PCR screening performed mid-February. The rate of patients over 65 years admitted to the ED decreased from 63% to 50% (p=0.001). The mean age of hospitalized patients in the infectious diseases ward decreased from 70.7 to 59.2 (p<0.001) while the proportion of patients without comorbidity increased from 16% to 42% (p=0.007). Neither the NEWS-2 score nor the main signs of clinical severity have changed over time.

Conclusion Spread of the UK-variant in the South East of France affects younger and healthier patients.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04779021

Funding Statement

The study was carried out as part of our routine work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The clinical research and Innovation Office of Nice University Hospital has waived the need for ethical oversight for this study. The database used for this study complies with act n78-17 of 6 january 1978 on information technology, data files and civil liberties amended by following laws and Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation). This database used in the Infectious Diseases Department of Nice university hospital is authorized by the French National Commission on Informatics and Liberty (number of registration: 1430722). A signed consent form is used in our hospital for each patient in order to enable the use of the clinical data recorded during current care for medical research. this study is registered on ClinicalTrials. Gov NCT04779021

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflict of interest statement: none to declare

  • Funding statement: The study was carried out as part of our routine work.

Data Availability

Data are available on request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 15, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Spread of the SARS-CoV-2 UK-variant in the South East of France: impact on COVID-19 patients’ age, comorbidity profiles and clinical presentation
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Spread of the SARS-CoV-2 UK-variant in the South East of France: impact on COVID-19 patients’ age, comorbidity profiles and clinical presentation
Johan Courjon, Julie Contenti, Elisa Demonchy, Jacques Levraut, Pascal Barbry, Géraldine Rios, Jean Dellamonica, David Chirio, Caroline Bonnefoy, Valérie Giordanengo, Michel Carles
medRxiv 2021.04.12.21253817; doi: https://doi.org/10.1101/2021.04.12.21253817
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Spread of the SARS-CoV-2 UK-variant in the South East of France: impact on COVID-19 patients’ age, comorbidity profiles and clinical presentation
Johan Courjon, Julie Contenti, Elisa Demonchy, Jacques Levraut, Pascal Barbry, Géraldine Rios, Jean Dellamonica, David Chirio, Caroline Bonnefoy, Valérie Giordanengo, Michel Carles
medRxiv 2021.04.12.21253817; doi: https://doi.org/10.1101/2021.04.12.21253817

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (214)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1091)
  • Dentistry and Oral Medicine (194)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (497)
  • Epidemiology (9747)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2298)
  • Geriatric Medicine (221)
  • Health Economics (461)
  • Health Informatics (1548)
  • Health Policy (729)
  • Health Systems and Quality Improvement (600)
  • Hematology (236)
  • HIV/AIDS (500)
  • Infectious Diseases (except HIV/AIDS) (11619)
  • Intensive Care and Critical Care Medicine (615)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2136)
  • Nursing (133)
  • Nutrition (332)
  • Obstetrics and Gynecology (424)
  • Occupational and Environmental Health (516)
  • Oncology (1171)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (308)
  • Pediatrics (692)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2168)
  • Public and Global Health (4640)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (450)
  • Respiratory Medicine (622)
  • Rheumatology (273)
  • Sexual and Reproductive Health (224)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (42)
  • Transplantation (120)
  • Urology (94)